BRCA1 and BRCA2 play an integral role in DNA mismatch repair. Patients who express a BRCA mutation have been shown to accumulate damaged DNA, which may stimulate oocyte aging and/or depletion.
BRCA1 carriers (=-4.5, p=0.02); however, BRCA2 carriers had a similar number of oocytes retrieved as compared with controls (=-1.7, p=0.49). Controlling for age, fertilization rate was not modified in BRCA carriers, however, there was a trend towards decreased blastulation rate in BRCA1 (=-0.15, p=0.07) and BRCA2 carriers (=-0.17, p=0.06). Controlling for age, aneuploidy rate was not modified in BRCA1 (=0.1, p=0.26) and BRCA2 carriers (=0.5, p=0.64).
Conclusions:
BRCA patients commonly undergo IVF and egg freezing and at an earlier age, most likely due to the recommendation for prophylactic salpingo-oophorectomy by age 35 to 40. Despite the subtle decrease in ovarian reserve and trend towards reduced blastulation rate seen in BRCA carriers, embryo quality, as measured by aneuploidy, was not affected. BRCA carriers undergoing COH for IVF or oocyte cryopreservation can be reassured that they will have outcomes comparable to the general population undergoing ART and of the achievability of their goals to grow their family. 
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